Lactalis acquires Aspen’s infant-formula unit for $860m to tap Chinese market Mother feeding baby. Photo: Tanaphong Toochinda/unsplash Janice Kew, Phil Serafino September 14, 2018 PremiumLactalis International agreed to buy an infant-formula business from Aspen Pharmacare Holdings Ltd for 739.8 million euros ($860 million) as the French dairy group targets the fast-growing Chinese market. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Should your colleagues be reading this article too? Contact us for corporate subscriptions at email@example.com.